Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | AMGN | VRTX | BMY | REGN |
| Company | Intra-Cellular Ther | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 71.07 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 71.35 | 322.60 | 405.67 | 44.33 | 947.08 |
| Low | 68.92 | 310.65 | 397.59 | 43.69 | 926.94 |
| Last | 69.02 | 312.15 | 401.10 | 43.86 | 946.67 |
| Change | -1.32 | +33.76 | +0.94 | +0.16 | +9.06 |
| % Change | -1.88% | +12.13% | +0.23% | +0.37% | +0.97% |
| Volume | 303,544 | 6,111,885 | 406,729 | 5,039,300 | 172,006 |
| 20-Day Average Volume | 1,420,213 | 2,462,434 | 988,577 | 14,097,813 | 499,302 |
| Previous Close | 70.34 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 71.33 | 272.40 | 398.40 | 47.46 | 909.23 |
| 20-Day Raw Stochastic | 24.81% | 86.13% | 59.25% | 7.21% | 93.34% |
| 20-Day Relative Strength | 48.41% | 72.99% | 46.61% | 28.92% | 55.98% |
| Weighted Alpha | +13.24 | +35.30 | +14.11 | -36.78 | +24.42 |
| Today's Opinion | 88% Buy | 24% Buy | 8% Buy | 100% Sell | 64% Buy |
| Previous Opinion | 88% Buy | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 56% Buy | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.41% since 04/26/24 | +16.31% since 04/26/24 | +0.75% since 04/26/24 | -2.04% since 04/26/24 | +6.91% since 04/26/24 |
| Low | 69.17 on 05/03/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 73.82 on 04/29/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 946.81 on 05/03/24 |
| 1-Month | |||||
| %Chg | +2.94% since 04/03/24 | +14.43% since 04/03/24 | -2.04% since 04/03/24 | -15.80% since 04/03/24 | -0.70% since 04/03/24 |
| Low | 64.15 on 04/15/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 84.89 on 04/16/24 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | +3.05% since 02/02/24 | -2.84% since 02/02/24 | -5.70% since 02/02/24 | -9.80% since 02/02/24 | -0.10% since 02/02/24 |
| Low | 62.78 on 02/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 84.89 on 04/16/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +26.02% since 11/03/23 | +16.36% since 11/03/23 | +6.45% since 11/03/23 | -16.82% since 11/03/23 | +15.59% since 11/03/23 |
| Low | 52.88 on 11/13/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 84.89 on 04/16/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,809,403 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 96,807 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 464,370,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -139,670,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 132,100,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -28,580,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.01 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 02/22/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |